gefitinib,osimertinib
astrazeneca
['gefitinib', 'sclc', 'lcsm,(-blcsm)', 'nsclc']
again ph3 study: chemo+ gefitinib or osi in egfrmut stiv nsclc os #asco23 #lcsm 
MD PhD, lung oncologist & researcher @IEOufficiale; @myESMO Communication Committee Chair; #LungCancer Molecular target-believer #LCSM